个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Chinese expert recommendation on transnasal corticosteroid nebulization for the treatment of chronic rhinosinusitis 2021

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE

作者：
Wang, Chengshuo[1,2,3,4] * ; Cheng, Lei[5,6,7] ; Li, Huabin[8] ; Liu, Zheng[9] ; Lou, Hongfei[1,2,3,4] ; Shi, Jianbo[10] ; Sun, Ying[1,2,3,11] ; Wang, Dehui[8] ; Yang, Qintai[12] ; Yu, Hongmeng[8,13] ; Zhao, Changqing[14] ; Zhu, Dongdong[15] ; Cheng, Fengli[14] ; Li, Yan[1,2,3,4] ; Liao, Bo[9] ; Lu, Meiping[5,6] ; Meng, Cuida[15] ; Shen, Shen[1,2,3,4] ; Sun, Yueqi[16] ; Zheng, Rui[12] ; Zhang, Luo[1,2,3,4,17,*1] ;
单位： [1]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China [2]Beijing Inst Otolaryngol, Beijing Lab Allerg Dis, Beijing, Peoples R China [3]Beijing Inst Otolaryngol, Beijing Key Lab Nasal Dis, Beijing, Peoples R China [4]Chinese Acad Med Sci, Res Unit Diag & Treatment Chron Nasal Dis, Beijing, Peoples R China [5]Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Peoples R China [6]Nanjing Med Univ, Affiliated Hosp 1, Clin Allergy Ctr, Nanjing, Peoples R China [7]Nanjing Med Univ, Int Ctr Allergy Res, Nanjing, Peoples R China [8]Fudan Univ, Dept Otolaryngol Head Neck Surg, Eye & ENT Hosp, Shanghai, Peoples R China [9]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Otolaryngol Head & Neck Surg, Wuhan, Peoples R China [10]Sun Yat Sen Univ, Otorhinolaryngol Hosp, Affiliated Hosp 1, Guangzhou, Peoples R China [11]Capital Med Univ, Sch Basic Med Sci, Dept Immunol, Beijing, Peoples R China [12]Sun Yat Sen Univ, Affiliated Hosp 3, Dept Otorhinolaryngol Head & Neck Surg, Dept Allergy, Guangzhou, Peoples R China [13]Chinese Acad Med Sci, Res Units New Technol Endoscop Surg Skull Base Tu, Shanghai, Peoples R China [14]Shanxi Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Hosp 2, Taiyuan, Peoples R China [15]Jilin Univ, Dept Otorhinolaryngol Head & Neck Surg, China Japan Union Hosp, Changchun, Peoples R China [16]Sun Yat Sen Univ, Affiliated Hosp 7, Dept Otolaryngol, Shenzhen, Peoples R China [17]Capital Med Univ, Beijing Tongren Hosp, Dept Allergy, Beijing, Peoples R China
出处：
DOI： 10.21037/jtd-21-1142
ISSN：

关键词： Chronic rhinosinusitis (CRS) corticosteroids efficacy safety transnasal nebulization

摘要：
Corticosteroids are efficacious in treating chronic rhinosinusitis (CRS), but concerns on the potential side effects remain, especially for long-term usage of systemic corticosteroids. Accumulated evidence shows that transnasal nebulization may be a reasonable solution in balancing both efficacy and safety. However, no consensus or guideline has been formulated on the use of steroid transnasal nebulization in treating CRS. The consensus is achieved through literature review and exchange of Chinese experts in Group of Otorhinolaryngology and Ophthalmology, Chinese Society of Allergy (CSA). This document covers the development, equipment, pharmacological mechanism, and evidence-based efficacy and safety, as well as the special concern of the application of steroid transnasal nebulization during the coronavirus disease (COVID-19) pandemic. The expert consensus clarifies the application of steroid transnasal nebulization in treating CRS and common comorbidities during the perioperative and postoperative periods.

基金：
national natural science foundation of China [81630023, 81970850, 81870698, 82025010]; National Key R & D Program of China [2018YFC0116800]; CAMS Innovation Fund for Medical Sciences (CIFMS) [2019-I2M-5-022, 2021-I2M-CT-B-098]; Program for Changjiang Scholars and Innovative Research Team [IRT13082]; Beijing Municipal Science and Technology Project [Z181100001618002]
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2020]版：
大类 | 4 区 医学
小类 | 4 区 呼吸系统
最新[2025]版：
大类 | 4 区 医学
小类 | 4 区 呼吸系统
JCR分区：
出版当年[2019]版：
Q3 RESPIRATORY SYSTEM
最新[2023]版：
Q3 RESPIRATORY SYSTEM

影响因子： 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者：
第一作者单位： [1]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China [2]Beijing Inst Otolaryngol, Beijing Lab Allerg Dis, Beijing, Peoples R China [3]Beijing Inst Otolaryngol, Beijing Key Lab Nasal Dis, Beijing, Peoples R China [4]Chinese Acad Med Sci, Res Unit Diag & Treatment Chron Nasal Dis, Beijing, Peoples R China
通讯作者：
通讯机构： [1]Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China [2]Beijing Inst Otolaryngol, Beijing Lab Allerg Dis, Beijing, Peoples R China [3]Beijing Inst Otolaryngol, Beijing Key Lab Nasal Dis, Beijing, Peoples R China [4]Chinese Acad Med Sci, Res Unit Diag & Treatment Chron Nasal Dis, Beijing, Peoples R China [17]Capital Med Univ, Beijing Tongren Hosp, Dept Allergy, Beijing, Peoples R China [*1]Beijing Tongren Hosp, 1 Dongjiaominxiang, Beijing 100005, Peoples R China
推荐引用方式(GB/T 7714)：
Wang Chengshuo,Cheng Lei,Li Huabin,et al.Chinese expert recommendation on transnasal corticosteroid nebulization for the treatment of chronic rhinosinusitis 2021[J].JOURNAL OF THORACIC DISEASE.2021,13(11):6217-6229.doi:10.21037/jtd-21-1142.
APA：
Wang, Chengshuo,Cheng, Lei,Li, Huabin,Liu, Zheng,Lou, Hongfei...&Zhang, Luo.(2021).Chinese expert recommendation on transnasal corticosteroid nebulization for the treatment of chronic rhinosinusitis 2021.JOURNAL OF THORACIC DISEASE,13,(11)
MLA：
Wang, Chengshuo,et al."Chinese expert recommendation on transnasal corticosteroid nebulization for the treatment of chronic rhinosinusitis 2021".JOURNAL OF THORACIC DISEASE 13..11(2021):6217-6229

相关文献

[1]Comparison of the efficacy and safety of mometasone furoate to other inhaled steroids for asthma: a meta-analysis [2]Comparison of the efficacy and safety of mometasone furoate to other inhaled steroids for asthma: A meta-analysis [3]Efficacy and Safety of Empagliflozin in NODAT [4]Effect of Fecal Microbiota Transplantation (FMT) in Pediatric Functional Gastrointestinal Disorders [5]Safety and Efficacy Study of Omalizumab to Treat Allergic Asthma [6]the Safety and Efficacy of SENL103 Autologous T Cell Injection [7]阿托品在儿童及青少年近视治疗中应用的研究进展 [8]门冬胰岛素30注射液治疗糖尿病的疗效及安全性比较:多中心、随机、开放、对照研究 [9]Efficacy and Safety Evaluation of BCMA-UCART [10]Efficacy and Safety of Abelmoschus Manihot for IgA Nephropathy

资源点击量：589 今日访问量：0 总访问量：441 更新日期：2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）